We used double-immunolabelling with various size gold particles in label-fracture replicas to gain information on the subunit composition of GABAA receptors in clusters located in the plasma membrane of cultured cerebellar granule cells. We hypothesize that if two subunits colocalize in the same GABAA receptor, the density of the label of any given subunit decreases when another subunit of the same receptor complex is prelabelled with an antibody linked to a gold particle of larger size. Following this hypothesis, the interpretation of our results allows to suggest that a consistent receptor colocalization of beta 2/3 with alpha 1 or alpha 6 subunits may be operative in cerebellar granule cells. The decrease in the density of the second labelling in double-labelling experiments using the alpha 1 and gamma 2 antibodies suggests that these subunits colocalize in the same receptor complex, this may be also true for the alpha 6 and gamma 2 subunits. When one prelabels the delta subunit the intensity of labelling of the alpha 1 subunit fails to change but that of the alpha 6 subunit decreases significantly, suggesting a consistent colocalization of alpha 6 and delta but not of alpha 1 and delta. Finally, when one prelabels the alpha 1 subunit the intensity of labelling for the alpha 6 subunit fails to change, suggesting that these subunits do not colocalize in the same receptor complex. We conclude that in the GABAA receptors expressed in granule cells the alpha 1 subunit is preferentially colocalized with the beta 2-3 and gamma 2 subunits, while the alpha 6 subunit is preferentially colocalized with the beta 2-3 and either the delta or the gamma 2 subunit. This conclusion is supported by parallel experiments in which the sequence of labelling is inverted.
Download full-text PDF |
Source |
---|
Front Neurosci
January 2025
Department of Geriatric Rehabilitation, Jiangbin Hospital, Nanning, China.
Background: Programmed cell death plays an important role in neuronal injury and death after ischemic stroke (IS), leading to cellular glucose deficiency. Glucose deficiency can cause abnormal accumulation of cytotoxic disulfides, resulting in disulfidptosis. Ferroptosis, apoptosis, necroptosis, and autophagy inhibitors cannot inhibit this novel programmed cell death mechanism.
View Article and Find Full Text PDFEur J Med Chem
January 2025
State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, 1 Xiannongtan Street, Xicheng district, Beijing, 100050, China. Electronic address:
A novel class of 7-phenyl-[1,2,4]triazol-5(4H)-one derivatives was designed and synthesized, and their in vivo anticonvulsant activities were evaluated using subcutaneous pentylenetetrazole (Sc-PTZ) and maximal electroshock (MES) tests. Compounds 3u, 4f and 4k exhibited significant anticonvulsant activities in the Sc-PTZ model with ED values of 23.7, 17.
View Article and Find Full Text PDFPLoS Biol
January 2025
Cardiovascular Institute and Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Definitive hematopoietic stem and progenitor cells (HSPCs) arise from a small number of hemogenic endothelial cells (HECs) within the developing embryo. Understanding the origin and ontogeny of HSPCs is of considerable interest and potential therapeutic value. It has been proposed that the murine placenta contains HECs that differentiate into HSPCs.
View Article and Find Full Text PDFPlant Dis
January 2025
Hainan University School of Tropical Agriculture and Forestry, Haikou, Hainan, China;
Katsumada galangal seed ( K. Schum) is an important member of the Zingiberaceae family, with both medicinal value and culinary applications (Park et al. 2020).
View Article and Find Full Text PDFJ Dermatolog Treat
December 2025
Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.
Purpose: Dupilumab is a widely recommended treatment for moderate-to-severe atopic dermatitis (AD), with known ocular side effects but less frequent cutaneous reactions.
Material And Methods: This case report details a 52-year-old female patient with atopic dermatitis treated with dupilumab. After an initially successful treatment, the patient developed a rosacea-like dermatitis.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!